With confidence dropping in doing business with China-affiliated life sciences companies due to the Biosecure Act, one of the companies explicitly named in the U.S. legislation is fighting back. Raising the possibility of a constitutional challenge to the bill, Rade Drmanac, co-founder and chief scientific officer of Complete Genomics Inc., wrote to congressional leaders to urge them to remove the California-based subsidiary of MGI from the bill.

New hires and promotions in the med-tech industry, including: Caredx, Carlsmed, Livanova, Quidelortho, Rhine Air.

Med-tech firms raising money in public or private financings, including: Conavi Medical, Titan Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bellaseno, Neurorelief.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditxt, Amwell, Apogepha, Avania, Baird Medical, Biolase, Evofem, Hello Heart, J&J, Jointvue, Nanovibronix, Smith+Nephew, Sonendo, V-Wave.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Sprinkbok.

David Baker, Demis Hassabis and John Jumper share the 2024 Nobel Prize in Chemistry for their contributions to the science of protein structure. David Baker was awarded half the prize “for computational protein design,” according to the Royal Swedish Academy of Sciences. Hassabis and Jumper shared the other half “for protein structure prediction.”